Gadia, Viviano S.
HRN: 23-28-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/01/2023
07/08/2023
IV
600mg
QID
Infected Wound
Waiting Final Action
Indication: Empirical Escalation Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes